Phase 2 TRANQUILITY trial surpasses enrollment target, with 143 total patients enrolled; topline data expected in second quarter of 2025 –– ...
The battery, developed by the University of Bristol and the UK Atomic Energy Authority, leverages the radioactive isotope ...